Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial
- DOI
- 10.1136/svn-2025-004582
- Published
- 2025-12-04
- Container
- Stroke and Vascular Neurology
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/svn-2025-004582,
title = {Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial},
author = {Shuya Li and Xuechun Wang and Baoyu Feng and Hao Li and Yongjun Wang},
year = {2025},
journal = {Stroke and Vascular Neurology},
doi = {10.1136/svn-2025-004582},
url = {https://doi.org/10.1136/svn-2025-004582}
}RIS
TY - JOUR TI - Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial AU - Shuya Li AU - Xuechun Wang AU - Baoyu Feng AU - Hao Li AU - Yongjun Wang PY - 2025 JO - Stroke and Vascular Neurology DO - 10.1136/svn-2025-004582 UR - https://doi.org/10.1136/svn-2025-004582 ER -
APA
Li, S., Wang, X., Feng, B., Li, H., & Wang, Y. (2025). Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2025-004582
Source records
- crossref · retrieved 2026-09-26T22:13:07.599Z